Market Watch
Shares of Moderna Inc. MRNA, -0.23% were up 2.3% in premarket trading on Wednesday, the day after the company’s stock price hit an all-time high of $234.60 when the market closed on Tuesday. Moderna has one authorized product, its two-dose, mRNA-based COVID-19 vaccine; the global success of its shot, along with BioNTech BNTX, 0.07% and Pfizer Inc.’s PFE, 0.83% COVID-19 vaccine, has opened the door for broader interest in mRNA technology. Moderna’s stock has soared 124.4% so far this year, while the S&P 500 SPX, 0.50% is up 14.2%.
READ FULL ARTICLE HERE > https://www.marketwatch.com/story/modernas-stock-hits-record-price-on-tuesday-2021-06-30